The experimental group shows that in rats the weight of the transplanted tumor is significantly reduced, and it can be seen that the Smad2 signaling pathway can indeed release inhibitors to reduce the proliferation of liver cancer cells. The gene discussed is SMAD2; the disease is liver cancer.